ITGR vs REGN · P/E 23, rev $1.72B vs P/E 14, rev $14.34B
Integer Holdings Corp (ITGR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Integer Holdings Corp (ITGR) is a medical devices company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ITGR revenue for 2024-12-31 was $1.72B. Net income was $119.9M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ITGR currently screens at market cap $3.14B and trailing P/E 23.0.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ITGR currently screens at market cap $3.14B and trailing P/E 23.0. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ITGR and REGN stock pages for the full models.
Not investment advice.